These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7889326)

  • 21. Mechanism of antibiotic efflux in Gram-negative bacteria.
    Zgurskaya HI; Krishnamoorthy G; Tikhonova EB; Lau SY; Stratton KL
    Front Biosci; 2003 Sep; 8():s862-73. PubMed ID: 12957812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in understanding bacterial outer-membrane biogenesis.
    Ruiz N; Kahne D; Silhavy TJ
    Nat Rev Microbiol; 2006 Jan; 4(1):57-66. PubMed ID: 16357861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria.
    Pagès JM; Amaral L
    Biochim Biophys Acta; 2009 May; 1794(5):826-33. PubMed ID: 19150515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug efflux pumps of gram-negative bacteria.
    Nikaido H
    J Bacteriol; 1996 Oct; 178(20):5853-9. PubMed ID: 8830678
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular mechanisms of AcrB-mediated multidrug export.
    Zwama M; Yamaguchi A
    Res Microbiol; 2018; 169(7-8):372-383. PubMed ID: 29807096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Li XZ; Plésiat P; Nikaido H
    Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of Vibrio vulnificus RND efflux pumps homologous to Vibrio cholerae VexAB and VexCD, and to Escherichia coli AcrAB.
    Lee S; Yeom JH; Seo S; Lee M; Kim S; Bae J; Lee K; Hwang J
    J Microbiol; 2015 Apr; 53(4):256-61. PubMed ID: 25740377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V
    Pathol Biol (Paris); 2004 Dec; 52(10):607-16. PubMed ID: 15596311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of NlpE overproduction on multidrug resistance in Escherichia coli.
    Nishino K; Yamasaki S; Hayashi-Nishino M; Yamaguchi A
    Antimicrob Agents Chemother; 2010 May; 54(5):2239-43. PubMed ID: 20211889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteria.
    Livermore DM
    Rev Infect Dis; 1988; 10(4):691-8. PubMed ID: 3142011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biotinylation facilitates the uptake of large peptides by Escherichia coli and other gram-negative bacteria.
    Walker JR; Altman E
    Appl Environ Microbiol; 2005 Apr; 71(4):1850-5. PubMed ID: 15812011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
    Pagès JM; Amaral L; Fanning S
    Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efflux-mediated drug resistance in bacteria.
    Li XZ; Nikaido H
    Drugs; 2004; 64(2):159-204. PubMed ID: 14717618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
    Schweizer HP
    Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The MFS efflux proteins of gram-positive and gram-negative bacteria.
    Saidijam M; Bettaney KE; Leng D; Ma P; Xu Z; Keen JN; Rutherford NG; Ward A; Henderson PJ; Szakonyi G; Ren Q; Paulsen IT; Nes I; Kroeger JK; Kolsto AB
    Adv Enzymol Relat Areas Mol Biol; 2011; 77():147-66. PubMed ID: 21692369
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria.
    Masi M; Réfregiers M; Pos KM; Pagès JM
    Nat Microbiol; 2017 Feb; 2():17001. PubMed ID: 28224989
    [No Abstract]   [Full Text] [Related]  

  • 40. Multicomponent drug efflux complexes: architecture and mechanism of assembly.
    Zgurskaya HI
    Future Microbiol; 2009 Sep; 4(7):919-32. PubMed ID: 19722844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.